Hexbyte  Tech News  Wired The Case for Expensive Antibiotics

Hexbyte Tech News Wired The Case for Expensive Antibiotics

|

Douglas Sacha/Getty ImagesDouglas Sacha/Getty ImagesA handful of years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot.The manufacturer is called Nostrum…